Skip to main content
SpringerLink
Log in

Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM

  • Originals
  • Published:
Diabetologia Aims and scope Submit manuscript

Summary

The relationship between diabetic nephropathy and an insertion (I)/deletion (D) polymorphism in intron 16 of the angiotensin-converting enzyme (ACE) gene is still under debate. The association of ACE gene polymorphism with nephropathy and retinopathy was therefore examined in 362 Japanese patients with non-insulin-dependent diabetes mellitus (NIDDM) and 105 healthy control subjects. Distribution of the ACE genotype did not differ between healthy control subjects and diabetic patients without complications. However, the frequency of the D allele was significantly higher in the diabetic subjects with nephropathy than in those without (0.32 in normoalbuminuric patients vs 0.44 in albuminuria patients with albuminuria) (χ2=7.7; p=0.006). There was no significant association between ACE genotype and retinopathy. These observations thus demonstrate a significant association of the ACE gene polymorphism with nephropathy, but not with retinopathy, in Japanese patients with NIDDM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ACE:

Angiotensin-converting enzyme

IDDM:

insulin-dependent diabetes mellitus

NIDDM:

non-insulin-dependent diabetes mellitus

UAI:

urinary albumin index

PCR:

polymerase chain reaction

References

  1. Klein R, Klein BE, Moss S, DeMets DL (1988) Proteinuria in diabetes. Arch Intern Med 148: 181–186

    PubMed  Google Scholar 

  2. Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in type I (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596

    Article  PubMed  Google Scholar 

  3. Rettig P, Teutsch S (1984) The incidence of end-stage renal disease in type I and type II diabetes mellitus. Diabetic Nephropathy 3: 26–27

    Google Scholar 

  4. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE (1992) Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 41: 731–735

    PubMed  Google Scholar 

  5. Klein R, Klein BE, Moss SE (1984) The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520–526

    PubMed  Google Scholar 

  6. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527–532

    PubMed  Google Scholar 

  7. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161–1165

    PubMed  Google Scholar 

  8. Borch-Johonsen K, Norgaard K, Hommel E et al. (1992) Is diabetic nephropathy an inherited complication? Kidney Int 41: 719–722

    PubMed  Google Scholar 

  9. Parving HH, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 297: 1086–1091

    PubMed  Google Scholar 

  10. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med 329:1456–1462

    PubMed  Google Scholar 

  11. Zatz R, Meyer TW, Rennke HG, Brenner BM (1985) Predominance of haemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963–5967

    PubMed  Google Scholar 

  12. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930

    PubMed  Google Scholar 

  13. Anderson S, Rennke HG, Garcia DL, Brenner BM (1989) Short and long term effects of anti-hypertensive therapy in the diabetic rat. Kidney Int 36: 526–536

    PubMed  Google Scholar 

  14. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343–1346

    PubMed  Google Scholar 

  15. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290: 33–40

    PubMed  Google Scholar 

  16. Tiret L, Rigat B, Visvikis S et al. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197–205

    PubMed  Google Scholar 

  17. Marre M, Bernadet P, Gallois Y et al. (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384–388

    PubMed  Google Scholar 

  18. Schmidt S, Schone N, Ritz E, and the Diabetic Nephropathy Study Group (1995) Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47: 1176–1181

    PubMed  Google Scholar 

  19. Tarnow L, Cambien F, Rossing P et al. (1994) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44(5):489–494

    Google Scholar 

  20. Fujisawa T, Ikegami H, GQ Shen et al. (1995) Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18: 983–985

    PubMed  Google Scholar 

  21. Group WS (1985) Report on diabetes mellitus. World Health Organization, Technical Report Series 727, Geneva

  22. Gatling W, Knight C, Mullee MA, Hill RD (1988) Microalbuminuria in diabetes; a population study of the prevalence and an assessment of three screening tests. Diabet Med 5: 343–347

    PubMed  Google Scholar 

  23. Cohen DL, Close CF, Viberti GC (1987) The variability of overnight urinary albumin excretion on insulin-dependent diabetic and normal subjects. Diabet Med 4: 437–440

    PubMed  Google Scholar 

  24. Tuji K, Aizawa M, Sasazuki T (1992) Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique, vol 1. Oxford University Press, Oxford, pp 397–419

    Google Scholar 

  25. Lindpaintner K, Pfeffer MA, Kreutz R et al. (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemie heart disease. N Engl J Med 332: 706–711

    Article  PubMed  Google Scholar 

  26. Lee EJ (1994) Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 37: 212–214

    PubMed  Google Scholar 

  27. Nomura H, Koni I, Michishita Y, Morise T, Takeda R (1994) Angiotensin-converting enzyme gene polymorphism in haemodialysis patients. Lancet 343: 482–483

    Article  Google Scholar 

  28. Mogensen C (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356–360

    PubMed  Google Scholar 

  29. Jarrett R, Viberti C, Argyropoulos A (1984) Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabet Med 1:17–19

    PubMed  Google Scholar 

  30. Schmiz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5:126–134

    PubMed  Google Scholar 

  31. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41: 736–741

    PubMed  Google Scholar 

  32. Cambien F, Poirier O, Lecerf L et al. (1993) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641–644

    Article  Google Scholar 

  33. Tiret L, Kee F, Poirier O et al. (1993) Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341: 991–992

    Article  PubMed  Google Scholar 

  34. Zhao Y, Higashimori K, Higaki J et al. (1994) Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 17: 55–57

    Google Scholar 

  35. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 8287: 1430–1432

    Article  Google Scholar 

  36. Mangili R, Bending JJ, Scott G, Li-LK, Gupta A, Viberti G (1988) Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318: 146–150

    PubMed  Google Scholar 

  37. Herman WH, Prior DE, Yassine MD, Weder AB (1993) Nephropathy in NIDDM is associated with cellular markers for hypertension. Diabetes Care 16: 815–818

    PubMed  Google Scholar 

  38. Cordonnier DJ, Zmirou D, Benhamou PY, Halimi S, Ledoux F, Guiserix J (1993) Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories. Diabetologia 36: 1109–1112

    PubMed  Google Scholar 

  39. Kikkawa R, Arimura T, Haneda M et al. (1993) Current status of type 2 (non-insulin-dependent) diabetic subjects on dialysis therapy in Japan. Diabetologia 36: 1105–1108

    PubMed  Google Scholar 

  40. Marian AJ, Yu QT, Workman R, Greve G, Roberts R (1993) Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342: 1085–1086

    Article  PubMed  Google Scholar 

  41. Ballard DJ, Humphrey LL, Melton LJ III et al. (1988) Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 37: 405–412

    PubMed  Google Scholar 

  42. Sasaki A, Horinouchi N, Hasegawa K, Uehara M (1986) Risk factors related to the development of persistent albuminuria among diabetic patients observed in a long-term follow-up. J of the Jpn Diabetes Soc 29: 1017–1023

    Google Scholar 

  43. Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH (1989) Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int 35: 681–687

    PubMed  Google Scholar 

  44. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501

    Article  PubMed  Google Scholar 

  45. Parving HH, Larsen M, Hommel E, Lund-Andersen H (1989) Effect of anti-hypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32: 440–444

    Article  PubMed  Google Scholar 

  46. Ferrari-Dileo G, Davis EB, Anderson DR (1987) Angiotensin binding sites in bovine and human retinal blood vessels. Invest Ophthalmol Vis Sci 28:1747–1751

    PubMed  Google Scholar 

  47. Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105:141–145

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Maidashi 3-1-1, Higashiku, 812, Fukuoka, Japan

    Y. Doi, H. Yoshizumi, M. Yoshinari, K. Iino, M. Yamamoto, K. Ichikawa, M. Iwase & M. Fujishima

Authors
  1. Y. Doi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Yoshizumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Yoshinari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Iino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Ichikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Iwase
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Fujishima
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Doi, Y., Yoshizumi, H., Yoshinari, M. et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39, 97–102 (1996). https://doi.org/10.1007/BF00400419

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00400419

Key words

Search

Navigation